Giant Cell Tumors: Clinical Trials

1 trial for Giant Cell Tumors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Giant Cell Tumors: new trials by email Literature Review of Giant Cell Tumors trials Research Report on Giant Cell Tumors

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
Pexidartinib, Placebo - Pigmented Villonodular Synovitis, Giant Cell Tumors of the Tendon Sheath
Phase 3CompletedDaiichi Sankyo1202015-05-112022-05-11

Narrower conditions

Giant Cell Tumor of Tendon Sheath (1)  ·  Synovitis, Pigmented Villonodular (1)

Broader conditions

Joint Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Connective Tissue (1)  ·  Neoplasms, Connective and Soft Tissue (1)  ·  Synovitis (1)  ·  Tendinopathy (1)

Interventions

pexidartinib (1)

Sponsors

Daiichi Sankyo (1)

Countries

Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 27041409, PMID 31229240, PMID 32755241, PMID 33289960, PMID 36001000, PMID 42132251

NIH funding

2014 (1)